Medical Weight Loss with Saxenda®, Mounjaro®, Wegovy®
Treatment Overview
At Verve Clinic, we offer clinically proven anti-obesity medications such as Saxenda® (Liraglutide), Mounjaro® (Tirzepatide) and Wegovy® (Semaglutide) to support safe and effective weight reduction under medical supervision. These treatments are ideal for patients struggling with stubborn weight gain, slow metabolism, or obesity-related health risks, and are prescribed as part of a holistic slimming program.
Key benefits
how it works
Saxenda® (Liraglutide): A daily injectable that mimics the natural GLP-1 hormone, helping to control appetite and calorie intake while improving blood sugar levels.
Mounjaro® (Tirzepatide): A next-generation dual GIP & GLP-1 receptor agonist that enhances insulin response, curbs hunger, and accelerates fat loss more effectively than single-pathway medications.
Wegovy® (Semaglutide): A once-weekly GLP-1 receptor agonist that helps reduce appetite, increase fullness, slow gastric emptying, and support significant long-term weight loss while also improving blood sugar control and metabolic health.
Treatment Process
Ongoing treatment with monthly doctor reviews
Noticeable weight reduction within 4–8 weeks (varies per individual)
Sustained results with consistent lifestyle & maintenance plan
Ongoing treatment with monthly doctor reviews
Noticeable weight reduction within 4–8 weeks (varies per individual)
Sustained results with consistent lifestyle & maintenance plan
Duration :
Best Results :
Longevity :